Birinci Basamakta Meme Hastalıklarına Yaklaşım

Authors

Kenan Teker
https://orcid.org/0000-0003-2466-7435
Semra Demirli Atıcı
https://orcid.org/0000-0002-8287-067X

Synopsis

This study, which addresses the approach, diagnosis, and screening methods for breast diseases in primary healthcare, emphasizes the vital importance of early diagnosis in breast cancer, the most common malignancy and leading cause of cancer deaths among women. Although benign conditions account for most patient presentations, proper management by physicians through anamnesis, physical examination, and risk assessment prevents unnecessary referrals while ensuring the early detection of high-risk patients. The clinical examination follows inspection and palpation steps to evaluate the axillary and supraclavicular lymph nodes. Mastalgia, the most frequent presenting complaint, is categorized as cyclic, non-cyclic, or extramammary, and is mostly managed with reassurance, dietary modifications, or medical therapy. In cases of mastitis, classified as lactational or non-lactational, continued milk drainage, antibiotic therapy, or specific follow-up regimens are applied. Pathological nipple discharge and newly developed nipple retractions require further investigation to rule out malignancy. Regarding diagnostic imaging, breast ultrasonography is preferred for women under 40, whereas mammography combined with ultrasonography is recommended for women aged 40 and older. According to national standards, biennial mammography is recommended for asymptomatic women over 40, while high-risk individuals with genetic carrier status or strong family history begin screening at an earlier age with MRI support.

References

Debbie Saslow, Judy Hannan, Janet Osuch, Marianne H. Alciati, et al. Clinical Breast Examination: Practical Recommendations for Optimizing Performance and Reporting. CA Cancer J Clin 2004;54;327-44.

Meme Kanseri Korunma, Tarama, Tanı, Tedavi ve İzlem Klinik Rehberi (Versiyon 1.0), Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü, 2020

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA. Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492.

Özmen V. Breast cancer in Turkey: Analysis of 20.000 patients with breast cancer. Eur-JBreast Health. 2019;15:141- 146. http://dx.doi.org/10.5152/ejbh.2019.4890

Güllüoğlu B, Birinci Basamak Sağlık Hizmetinde Meme Hastalıklarına Yaklaşım“Bulgular ve Tanı Yöntemleri’’, Türk Aile Hek Derg 2007; 11(2): 53-64

Brennan M, Houssami N, French J. Management of benign breast conditions. Part 1 – painful breasts. Aust Fam Physician 2005; 34: 143-4.

Tahir MT, Shamsudeen S. Mastalgia. 2021 Feb 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32965866.

Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. Mastalgia: a review of management. J Reprod Med. 2005;50(12):933-9. PMID: 16444894

Salzman B, Fleegle S, Tully AS. Common breast problems. Am Fam Physician. 2012;15;86(4):343-9.

Goodwin PJ, Miller A, Del Giudice ME, Singer W, Connelly P, Ritchie JW. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol. 1998;179(2):430-7.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Meme Hastalıkları Grubu. Meme Hastalıkları Tanı ve Tedavi Kilevuzu, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Matbaası, İstanbul, 2006.

Çakır T, Cingi A, Fıstıkçı N, Bez Y, Topçuoğlu V, Güllüoğlu BM. Organik bir nedene bağlı olmayan mastalji yakınması olan hastalarda telkinin yeri. Prospektif kesitsel çalışma. Meme Sağlığı Dergisi 2006; 2: 96-9.

Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc. 2004;79(3):353-72.

Hadi MS. Sports Brassiere: Is It a Solution for Mastalgia? Breast J. 2000;6(6):407-409.

Russell LC. Caffeine restriction as initial treatment for breast pain. Nurse Pract. 1989;14(2):36-7.

Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg. 2003;196(4):525-30.

Pruthi S, Wahner-Roedler DL, Torkelson CJ, Cha SS, Thicke LS, Hazelton JH, Bauer BA. Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study. Altern Med Rev. 2010;15(1):59-67.

Laas E, Touboul C, Kerdraon O, Catteau-Jonard S. Mastites inflammatoires et infectieuses du sein en dehors de la grossesse et de la période d’allait-ement : recommandations [Inflammatory and infectious breast mastitis outside of pregnancy and lactation: Guidelines]. J Gynecol Obstet Biol Reprod 2015;44(10):996-1016. doi: 10.1016/j.jgyn.2015.09.055.

Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;15;78(6):727-31. PMID: 18819238.

Blackmon MM, Nguyen H, Mukherji P. Acute Mastitis. 2021;21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32491714.

Schoenfeld EM, McKay MP. Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm? J Emerg Med. 2010;38(4):e31-4

Boakes E, Woods A, Johnson N, Kadoglou N. Breast Infection: A Review of Diagnosis and Management Practices. Eur J Breast Health. 2018;14(3):136-143.

Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases. 2014; 16;2(12):852-8.

Fetherston C. Risk factors for lactation mastitis. J Hum Lact. 1998;14(2):101-9.

Abou-Dakn M, Richardt A, Schaefer-Graf U, Wöckel A. Inflammatory Breast Diseases during Lactation: Milk Stasis, püerperal Mastitis, Abscesses of the Breast, and Malignant Tumors- Current and Evidence-Based Strategies for Diagnosis and Therapy. Breast Care. 2010;5(1):33-37.

Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol. 1984; 01;149(5):492-5.

Stachs A, Stubert J, Reimer T, Hartmann S. Benign Breast Disease in Women. Dtsch Arztebl Int. 2019;09;116(33-34):565-574.

Lannin DR. Twenty-two year experience with recurring subareolar abscess andlactiferous duct fistula treated by a single breast surgeon. Am J Surg. 2004;188(4):407-10.

Zaragoza Zaragoza C, Hostalet Robles F, Kosny P, Morcillo Rodenas MÁ. [Idiopathic granuloma-tous mastitis: a condition with no definitive treatment]. Cir Esp. 2013;91(9):615-6.

Sripathi S, Ayachit A, Bala A, Kadavigere R, Kumar S. Idiopathic granulomatous mastitis: a diagnostic dilemma for the breast radiologist. Insights Imaging. 2016;7(4):523-9.

Davis J, Cocco D, Matz S, Hsu CH, Brown MJ, Lee J, Bouton ME, Caruso DM, Komenaka IK. Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis. Surgery. 2019;166(6):1176-1180.

Simmons R, Adamovich T, Brennan M ve ark. Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 2003; 10: 113-6.

Goksel HA, Yagmurdur MC, Demirhan B ve ark. Management strategies for patients with nipple discharge. Langenbecks Arch Surg 2005; 390: 52-8.

Cady B, Steele GD Jr, Morrow M ve ark. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin 1998; 48:49-63.

Sandoval-Leon AC, Drews-Elger K, Gomez-Fernandez CR, Yepes MM, Lippman ME. Paget’s disease of the nipple. Breast Cancer Res Treat. 2013 Aug;141(1):1-12. doi: 10.1007/s10549-013- 2661-4.

Marques-Costa JC, Cuzzi T, Carneiro S, Parish LC, Ramos-e-Silva M. Paget’s disease of the breast. Skinmed. 2012 May-Jun;10(3):160-5; quiz 165. PMID: 22779098

Pruthi S. Detection and evaluation of a palpable breast mass. Mayo Clin Proc 2001; 76: 641-8.

Kepple J, Klimberg VS. Management of benign breast mass. Prob Gen Surg 2003; 20: 56-65.

Irwig L, Macaskill P, Houssami N. Evidence relevant to the investigation of breast symptoms; the triple test. Breast 2002; 11: 215-20.

Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS, Screening for Breast Cancer Radiol Clin N Am 2017; 55: 1145–1162.

Sağlık Bakanlığı, Meme Kanseri Tarama Programı Ulusal Standartları (Erişim: 15 Aralık 2019) https://hsgm.saglik. gov.tr/tr/kanser-tarama-standartlari/listesi/meme-kanseri-tarama-programı-ulusal-standartları.html

Özmen V, Gürdal SÖ, Cabioğlu N, Özcinar B, Özaydın AN, Kayhan A, et al. Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project. Eur J Breast Health. 2017 Jul 1;13(3):117-122. doi: 10.5152/ejbh.2017.3528. eCollection 2017. PMID : 28894850

Saslow D, Boates C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:90–104.

Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997;277:997–1003

Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-76

Berg WA. Tailored supplemental screening for breast cancer: what now and what next?AJR Am J Roentgenol 2009;192(2):390-9

Gültekin S, Erbaş G, The Breast Cancer Screening Programs, the Past, Present and the Future, Turkiye Klinikleri J Med Oncol-Special Topics. 2018;11(1):13-22

Published

January 5, 2022

License

License